By modulating the metabolic activity of lipolytic genes, GDF15 is hypothesized to have diagnostic and therapeutic value in the treatment of IR, T2DM, obesity, and glycolipid metabolism [9]. The gene discussed is GDF15; the disease is obesity due to melanocortin 4 receptor deficiency.